Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of PB‐TURSO on the transcriptional and metabolic landscape of sporadic ALS fibroblasts
Jasmine A. Fels, Jalia Dash, Kent Leslie, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1551-1564
Open Access | Times Cited: 21

Showing 21 citing articles:

Unraveling the Heterogeneity of ALS—A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials
Laura Tzeplaeff, Alexandra V. Jürs, Camilla Wohnrade, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 452-452
Open Access | Times Cited: 8
Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
Emmanuelle C. Genin, Mélanie Abou-Ali, Véronique Paquis‐Flucklinger
Genes (2023) Vol. 14, Iss. 11, pp. 1981-1981
Open Access | Times Cited: 20
An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis
Yuyao Sun, Xiaoyan Li, Richard Bedlack
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 1-7
Closed Access | Times Cited: 19
Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment
Arsh Haj Mohamad Ebrahim Ketabforoush, Faezeh Faghihi, Fereshteh Azedi, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 495-512
Closed Access | Times Cited: 8
The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis
Kangqin Yang, Yang Liu, Min Zhang
Brain Sciences (2024) Vol. 14, Iss. 2, pp. 158-158
Open Access | Times Cited: 6
Therapeutic targeting ofALSpathways: Refocusing an incomplete picture
Nicholas J. Maragakis, Mamede de Carvalho, Michael D. Weiss
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 11, pp. 1948-1971
Open Access | Times Cited: 15
TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies
Pei‐Chuan Ho, Tsung‐Chi Hsieh, Kuen‐Jer Tsai
Ageing Research Reviews (2024) Vol. 100, pp. 102441-102441
Open Access | Times Cited: 4
Investigation of mitochondrial phenotypes in motor neurons derived by direct conversion of fibroblasts from familial ALS subjects
Evan Woo, Faiza Tasnim, Hibiki Kawamata, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Neurodegenerative diseases associated with the disruption of proteostasis and their therapeutic strategies using chemical chaperones
Takashi Sugiyama, Hideki Nishitoh
The Journal of Biochemistry (2024) Vol. 176, Iss. 3, pp. 179-186
Closed Access | Times Cited: 3
Pathophysiology of ion channels in amyotrophic lateral sclerosis
Robin N. Stringer, Norbert Weiss
Molecular Brain (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis
Loreto Martínez-González, Ana Martı́nez
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 2, pp. 141-160
Open Access | Times Cited: 7
Abnormal energy metabolism in ALS: a key player?
Thibaut Burg, Ludo Van Den Bosch
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 338-345
Open Access | Times Cited: 7
Assessing the efficacy of amyotrophic lateral sclerosis drugs in slowing disease progression: A literature review
Ubaid Ansari, Meraj Alam, Dawnica Nadora, et al.
AIMS neuroscience (2024) Vol. 11, Iss. 2, pp. 166-177
Open Access | Times Cited: 2
Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS
Soo Yeon Lee, Hye-Yeon Cho, Jung-Pyo Oh, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 6, pp. 1779-1795
Open Access | Times Cited: 5
Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy
S Seki, Y. Kitaoka, Sou Kawata, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2967-2967
Open Access | Times Cited: 5
Amyotrophic lateral sclerosis: exploring pathophysiology in the context of treatment
Angela Genge, Steven Wainwright, Christine Vande Velde
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2023) Vol. 25, Iss. 3-4, pp. 225-236
Closed Access | Times Cited: 4
Current neuroprotective therapies and future prospects for motor neuron disease
Laura J. Evans, David O’Brien, Pamela J. Shaw
International review of neurobiology (2024), pp. 327-384
Closed Access | Times Cited: 1
From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis
Lydia M. Castelli, Rosario Vasta, Scott P. Allen, et al.
International review of neurobiology (2024), pp. 209-268
Closed Access | Times Cited: 1
Discovery of Novel Inhibitors against ALS-Related SOD1(A4V) Aggregation through the Screening of a Chemical Library Using Differential Scanning Fluorimetry (DSF)
Μαρία Γιαννάκου, Ifigeneia Akrani, Angeliki Tsoka, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1286-1286
Open Access
A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis
Eleanor Roberts
EMJ Neurology (2023), pp. 2-12
Open Access
Discovery and characterization of novel inhibitors against ALS-related SOD1(A4V) aggregation through screening of a chemical library using Differerential Scanning Fluorimetry (DSF)
Μαρία Γιαννάκου, Constantinos E. Vorgias, Dimitris G. Hatzinikolaou
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top